These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 3008052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S, Kuoppala T, Leppilampi M, Vuori J, Kauppila A.
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 5. [Tumor markers in gynecologic diseases].
    Geyer H, Kleine W.
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer.
    Gadducci A, Ferdeghini M, Prontera C, Moretti L, Pellagatta L, Bianchi R, Fioretti P.
    J Nucl Biol Med (1991); 1991 Mar; 35(1):33-7. PubMed ID: 1657201
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR, Wang EY, Wang XX, Jia XH, Li L.
    Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G, Zippel HH, Würz H.
    Cancer Detect Prev; 1985 Mar; 8(1-2):135-9. PubMed ID: 3864535
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 17. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y, Furuno K, Sano Y, Hirata T, Utsunomiya A, Nakajima H, Okabe K, Shimizu K, Akiya K, Fujiwara Y.
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [Abstract] [Full Text] [Related]

  • 18. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R, Kaesemann H, Caffier H.
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [Abstract] [Full Text] [Related]

  • 19. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [Abstract] [Full Text] [Related]

  • 20. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994 Sep; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.